<DOC>
	<DOCNO>NCT01136746</DOCNO>
	<brief_summary>The purpose study compare use insulin glargine plus insulin lispro human regular insulin treatment hyperglycemia hospital set patient without know prior history diabetes .</brief_summary>
	<brief_title>Hospital Management Hyperglycemia Study Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin</brief_title>
	<detailed_description>This study involve comparison 2 method administer subcutaneous insulin therapy non-critically ill adult patient hyperglycemia without know history diabetes admit non-intensive care unit ( ICU ) general medical hospital service . Basal-bolus therapy , consider gold standard glucose control patient know diabetes , compare slide scale insulin , commonly use method glucose control ( prevail standard practice ) hospitalize patient . In study , basal-bolus therapy consist once-daily glargine plus lispro 3 4 time daily adjust achieve pre-meal capillary plasma glucose &lt; 140 milligram per deciliter ( mg/dL ) bedtime capillary plasma glucose &lt; 180 mg/dL patient eat [ predose plasma glucose &lt; 140 mg/dL patient nil per o ( NPO ) order ] ; slide scale insulin administer use human regular insulin 4 time daily need adjust achieve predose capillary plasma glucose target &lt; 140 mg/dL patient eat NPO order .</detailed_description>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Major No known history diabetes Admission preentry plasma glucose ( PG ) level 140 400 mg/dL Noncritically ill admit acute care medical service Have body mass index great equal 18.5 kg/m^2 less equal 45 kilogram per square meter ( kg/m^2 ) Major Received insulin/analog therapy longer 108 hour prior study entry intermediate longacting insulin/analogs ( neutral protamine Hagedorn , detemir , glargine ) 24 hour prior randomization intravenous insulin therapy prior randomization Laboratory evidence diabetic ketoacidosis patient prerandomization PG great 250 mg/dL Have take oral injectable antihyperglycemic medication insulin within 3 month prior study entry Have acute critical illness expect require admission ICU equivalent treat glucocorticoid therapy hospital study period Expected hospitalization le 24 hour postrandomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Hyperglycemia</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Hospital</keyword>
	<keyword>Diabetic</keyword>
</DOC>